Reporting and Analysis Plan - ECHO Analyses From Randomized Controlled Trials of Dabrafenib to Evaluate the Potential for Cardiac Valve Abnormalities (201709)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  BRF113683, MEK115306, MEK116513, BRF115532
• Data sources (types):
  Other
• Data sources (types), other:
  Phase III randomized studies

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No